Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mikelan LA vs Timoptol XE in Glaucoma/Ocular Hypertension
NCT00972426Phase 4Completed
- Sponsor
- Otsuka Holdings
- Start
- Oct 2009
- Primary completion
- Aug 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of Carteolol in Primary Open Angle Glaucoma (POAG), ocular hypertension, sponsored by Otsuka Holdings. Started Oct 2009; status: completed.
02
Drugs
Carteolol
03
Conditions
Primary Open Angle Glaucoma (POAG)ocular hypertension
Beyond the preview
Go deeper on NCT00972426.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00972426.